Chemomab Therapeutics Ltd. Cash Flows From Used In Financing Activities
Chemomab Therapeutics Ltd. (CMMB) reported Cash Flows From Used In Financing Activities of $21.16 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-24.
Discontinued › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2019-04-24
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2018-12-31 | $21.16M 20-F · filed 2019-04-24 |
| 2017-12-31 | $5.24M 20-F · filed 2019-04-24 |
| 2016-12-31 | $6.06M 20-F · filed 2019-04-24 |